Pathological Mechanisms Involved in HIV-Associated Lymphomagenesis: Novel Targeted Therapeutic Approaches
Open Access
Abstract
The intricate interplay of direct and indirect mechanisms relating to immune dysfunction, chronic inflammation, and viral proteins represents a key factor of lymphomagenesis in HIV-infected patients. Indirect mechanisms based on cytokine dysregulation, HIV-induced immune dysfunction, and co-infections with oncogenic viruses induce chronic B-cell activation and generation of a prone environment for malignant transformation and tumor growth. Direct mechanisms arise from oncogenic influences of p17, Tat, and Nef HIV proteins, which generate genomic instability, alteration of cellular signaling, and activation of oncogenic pathways. Vp17’s implication in lymphomagenesis and angiogenesis, ensured by activation of PAR1/EGFR/PI3K/Akt and MEK/ERK1/2 pathways, emphasizes the critical need for developing therapeutic strategies that target their signaling mechanisms. This review shows an insight into the pathological mechanisms involved in lymphomagenesis in HIV-infected individuals, focusing on finding novel therapeutic approaches directed at immune rehabilitation and oncogenic signaling pathways.Keywords
Funding Information
- PNRR/2022/C9/MCID/I8-Development of a program to attract highly specialized human resources from abroad in research, development, and innovation activities (760252/28.12.2023)
This publication has 90 references indexed in Scilit:
- Tumour-associated macrophages in diffuse large B-cell lymphoma: the prognostic and therapeutic impact in a South African centre with high HIV seroprevalenceImmunologic Research, 2024
- Human immunodeficiency virus-associated lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAnnals of Oncology, 2024
- Patterns of immune checkpoint protein expression in MYC-overexpressing aggressive B-cell non-Hodgkin lymphomasCancer Immunology, Immunotherapy, 2020
- Irreversible phenotypic perturbation and functional impairment of B cells during HIV-1 infectionFrontiers of Medicine, 2017
- MicroRNA regulation of viral immunity, latency, and carcinogenesis of selected tumor viruses and HIVReviews in Medical Virology, 2015
- Identification of a Small‐Molecule Inhibitor of HIV‐1 Assembly that Targets the Phosphatidylinositol (4,5)‐bisphosphate Binding Site of the HIV‐1 Matrix ProteinChemMedChem, 2013
- Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United StatesCancer, 2010
- Inhibition of HIV‐1 replication in primary human T cells transduced with an intracellular anti‐HIV‐1 p17 antibody geneThe Journal of Gene Medicine, 2003
- Association of JNK1 with p21waf1 and p53: Modulation of JNK1 activityMolecular Carcinogenesis, 2002
- The Development of AIDS-Associated Burkitt's/Small Noncleaved Cell Lymphoma Is Preceded by Elevated Serum Levels of Interleukin 6Clinical Immunology, 1999